Leading AI in clinical trials companies by funding worldwide 2023
Silicon Valley-based company Saama is so far among the AI companies involved in clinical trials which raised the largest amount of capital, totaling some half a billion U.S. dollars. Clinical trials are a crucial phase in drug development, but only about one out of 10 candidates progress from phase I to approval. Challenges like funding gaps, low enrollment, and flawed designs often lead to trial failures, despite a drug's safety and efficacy. AI's integration in clinical trials can make them more cost-effective and focused, potentially improving drug development's success rate.